Gefitinib in combination with 5-Fluorouracil (5-FU)/ Folinic Acid and Irinotecan in patients with 5-FU/ Oxaliplatin refractory colorectal cancer: A Phase I/II Study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO) / R.-D. Hofheinz; S. Kubicka; J. Wollert; D. Arnold; A. Hochhaus

Colorectal cancer · 5-Fluorouracil · Gefitinib · Irinotecan · Phase I study

Saved in:
Persons: Hofheinz, Ralf-Dieter [Other]; Kubicka, Stefan [Other]; Wollert, Jörg [Other]; Arnold, Dirk [Other]; Hochhaus, Andreas [Other]
Format: eArticle
Language(s):English
Publication:2006
Part of:Onkologie 29(2006), 12, Seite 563-7
ISSN:1423-0240
DOI:10.1159/000096449